Displaying 111 - 120 of 243
Alternative Name: LNG Contraceptive IUS (LCS); LCS16
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: Bayer HealthCare
Project Stage: SRA/WHO PQ Approved
Alternative Name: LDH-C4, Lactate dehydrogenase C
Target
Active Status: Yes
User: Male
Mode: No
Delivery Type: Oral
Developer: Northwestern University
Role in reproduction: Sperm Function
Project Stage: Target Identification
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: ContraMed, LLC
Project Stage: Phase II
Alternative Name: Pericoital LNG gel
Active Status: No
User: Female
Mode: Yes
Delivery Type: Vaginal Gel
Developer: Population Council
Project Stage: Phase I
Alternative Name: Zarin; Femplant; Trust; Sino-implant (II)
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: FHI 360, Shanghai Dahua Pharmaceuticals, Ltd.
Project Stage: Marketed
Alternative Name: Leukemia inhibitory factor (LIF) and interleukin-11 (IL-11)
Target
Active Status: No
User: Female
Mode: No
Developer: Prince Henry's Institute of Medical Research, Australia
Role in reproduction: Implantation
Project Stage: Target Validation
Alternative Name: Levosert (U.K.); Erlacela (Portugal); Donasert (Romania); Avibela
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: Actavis, Medicines360
Project Stage: SRA/WHO PQ Approved
Alternative Name: FC-Patch Low; Gestodene (GES) + ethinyl estradiol (EE) Patch
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Transdermal
Developer: WHO HRP, Bayer HealthCare, Gedeon Richter Plc.
Project Stage: SRA/WHO PQ Approved
Active Status: Yes
Mode: Yes
Delivery Type: Injectable
Developer: WHO HRP, CONRAD, NICHD
Project Stage: Phase I
Alternative Name: Twirla; AG200-15; Levonorgestrel + ethinyl estradiol patch
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Transdermal
Developer: Agile Therapeutics
Project Stage: Phase III
Pages
